Skip to content
Screener

McKesson MCK Impairment Charges

Impairment Charges at other companies

Viatris logo
ViatrisVTRS
$0-100%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$6.1M+11.9%
Doximity logo
DoximityDOCS
$0
Omnicell logo
OmnicellOMCL
$0
Baxter International logo
Baxter InternationalBAX
$0-100%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$100.24B+9.1%
Enterprise value$98.54B-2.2%
P/E21.1×-8.0×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetImpairmentCharges.

The source filing: McKesson’s 10-Q, filed February 4, 2026.

Filed
Feb 4, 2026, 5:30 PM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q4 2025
Accession
0000927653-26-000017
Line itemNine Months Ended December 31, 2025Nine Months Ended December 31, 2024
Adjustments to reconcile to net cash provided by (used in) operating activities:
Depreciation189182
Amortization344303
Asset impairment charges1083
Deferred taxes8150
Charges (credits) associated with last-in, first-out inventory method(28)85
Non-cash operating lease expense184179
Loss (gain) from sales of businesses and investments(85)571

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's impairment charges?
McKesson (MCK) reported impairment charges of $6M in Q4 2025.
How has McKesson's impairment charges changed year-over-year?
McKesson's impairment charges decreased by 14.3% year-over-year, from $7M to $6M.
What is the long-term trend for McKesson's impairment charges?
Over 2 years (2022 to 2025), McKesson's impairment charges has grown at a -25.2% compound annual growth rate (CAGR), from $175M to $98M.
What does impairment charges mean?
Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.

Ask your AI about McKesson's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude